1. Home
  2. SANG vs STXS Comparison

SANG vs STXS Comparison

Compare SANG & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

N/A

Current Price

$3.60

Market Cap

129.8M

Sector

Technology

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.32

Market Cap

139.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SANG
STXS
Founded
1984
1990
Country
Canada
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.8M
139.3M
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
SANG
STXS
Price
$3.60
$1.32
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
3.9K
486.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
$4.98
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.40
$1.24
52 Week High
$6.46
$3.59

Technical Indicators

Market Signals
Indicator
SANG
STXS
Relative Strength Index (RSI) 29.59 40.91
Support Level $3.44 $1.30
Resistance Level $3.80 $1.51
Average True Range (ATR) 0.11 0.06
MACD -0.04 -0.00
Stochastic Oscillator 0.00 22.45

Price Performance

Historical Comparison
SANG
STXS

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: